Backward regulations may prevent Europe from ever benefiting from easy-to-develop disease-resistant tomatoes

Screen Shot at AM

Engineering a tomato resistant to a pernicious fungal disease doesn’t seem like it’d be the easiest part of a plant pathologist’s job. But compared to getting that tomato to market? It’s a snap.

At least, that’s how Sophien Kamoun sees it. Kamoun studies plant diseases at the Sainsbury Laboratory in England, and in March [2017] his team published a paper describing a tomato they’d tweaked. Using the gene-editing technique Crispr/Cas9, Kamoun’s group snipped out a piece of a gene called Mildew Resistant Locus O, or Mlo. That deletion makes the tomato resistant to powdery mildew, a serious agricultural problem that takes a lot of chemicals to control.

But for now, that’s where Kamoun’s work stops. European regulations make the tomato essentially illegal—he and others can do the science, but probably can’t get it to field trials, and certainly can’t get it to market. “There’s more clarity in the US. One could probably get approval. But in Europe, it’s a big question mark,” he says. “I’m very frustrated by this, I have to be honest. Scientifically this plant is no different from any mutant we’d get from traditional breeding or traditional mutagenesis. I really don’t understand what the problem is.”

ADVERTISEMENT

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Who wants disease-resistant GM tomatoes? Probably not Europe

For more background on the Genetic Literacy Project, read GLP on Wikipedia

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend